Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Disc Dynamics spinal nucleus replacement

This article was originally published in The Gray Sheet

Executive Summary

Firm announces Aug. 2 approval to commence a clinical study of its Dascor disc arthroplasty system. Dascor is a minimally invasive nucleus replacement device intended for patients with disc degeneration not yet severe enough to warrant total disc replacement. Data from the trial, scheduled to begin during the third quarter, will support a premarket approval application for the device. The firm received a CE mark for Dascor in July 2005. Disc Dynamics is vying with NuVasive (NeoDisc), Cryolife (BioDisc) and Raymedica (PDN-Solo) to market the first spinal nucleus replacement system in the U.S. (1"The Gray Sheet" Sept. 5, 2005, p. 5)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023843

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel